HOFB.F Stock Overview
Hofseth BioCare ASA operates as a consumer and pet health ingredient supplier and incubator in Norway, the United Kingdom, France, Belgium, Europe, Japan, Asia, and the United States.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Hofseth BioCare ASA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr0.22 |
| 52 Week High | kr0.22 |
| 52 Week Low | kr0.22 |
| Beta | 0.47 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -78.00% |
| 3 Year Change | -77.08% |
| 5 Year Change | n/a |
| Change since IPO | -35.52% |
Recent News & Updates
Recent updates
Shareholder Returns
| HOFB.F | US Biotechs | US Market | |
|---|---|---|---|
| 7D | 0% | -2.5% | -3.2% |
| 1Y | -78.0% | -3.7% | 19.3% |
Return vs Industry: HOFB.F underperformed the US Biotechs industry which returned 10.4% over the past year.
Return vs Market: HOFB.F underperformed the US Market which returned 28.4% over the past year.
Price Volatility
| HOFB.F volatility | |
|---|---|
| HOFB.F Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 11.6% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: HOFB.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine HOFB.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 60 | Jon Odegard | www.hofsethbiocare.com |
Hofseth BioCare ASA operates as a consumer and pet health ingredient supplier in Norway and internationally. Its products include Brilliant salmon oil; OmeGo salmon oil for the maintenance of healthy cholesterol, joint, eye, brain, and cardiovascular function; ProGo, a salmon protein hydrolysate powder for treatment of irondeficiency anaemia, irritable bowel syndrome, and sarcopenia; CalGo, a marine calcium powder produced to support cartilage function, joint health, and bone strength; CollaGo; and PetGo, a non-soluble protein. Hofseth BioCare ASA was incorporated in 2009 and is headquartered in Ålesund, Norway.
Hofseth BioCare ASA Fundamentals Summary
| HOFB.F fundamental statistics | |
|---|---|
| Market cap | US$88.65m |
| Earnings (TTM) | -US$10.06m |
| Revenue (TTM) | US$20.60m |
4.3x
P/S Ratio-8.8x
P/E RatioIs HOFB.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HOFB.F income statement (TTM) | |
|---|---|
| Revenue | kr218.51m |
| Cost of Revenue | kr150.69m |
| Gross Profit | kr67.83m |
| Other Expenses | kr174.51m |
| Earnings | -kr106.68m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 19, 2024
| Earnings per share (EPS) | -0.27 |
| Gross Margin | 31.04% |
| Net Profit Margin | -48.82% |
| Debt/Equity Ratio | 332.5% |
How did HOFB.F perform over the long term?
See historical performance and comparison